Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass

De Somer, F; Van Belleghem, Y; Caes, F; François, K; Arnout, J; Bossuyt, X; Taeymans, Y; Van Nooten, G
January 2002
Perfusion;Jan2002, Vol. 17 Issue 1, p39
Academic Journal
Return of blood activated by tissue factor is the main culprit for triggering the coagulation cascade. When this activated blood is diverted from the cardiopulmonary bypass (CPB) circuit, it becomes possible to evaluate the effect of surface treatment on platelet and complement activation. Twenty adult patients undergoing elective coronary artery bypass grafting (CABG) were randomly assigned either to a control group (n = 10) or to a group in which the CPB circuit was completely coated with phosphorylcholine (n = 10). Plasma concentrations of platelet factor 4 (PF4), β-thromboglobulin (βTG), C3, C3d, C4, TCC, thrombin generation, haptoglobin and free haemoglobin, as well as blood loss, were measured. No significant differences between the two groups were found for haemolysis and thrombin generation. The mean total release of PF4 and βTG during CPB was 9338 ± 17303 IU/ml/CPB and 3790 ± 4104 IU/ml/CPB in the coated group versus 22192 ± 13931 IU/ml/CPB (p = 0.011) and 8040 ± 3986 IU/ml/CPB (p = 0.005) in the control group. Blood loss was 30% less in the coated group compared to the control group. Phosphorylcholine coating appears to have a favourable effect on blood platelets, which is most obvious after studying the changes during CPB. Clinically, this effect resulted in a 30% reduction in blood loss.


Related Articles

  • Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass Banz, Yara; Rieben, Robert; Zobrist, Claudia; Meier, Pascal; Shaw, Sidney; Lanz, Jonas; Carrel, Thierry; Berdat, Pascal // European Journal of Cardio-Thoracic Surgery;Sep2008, Vol. 34 Issue 3, p653 

    Abstract: Objective: Contact of blood with artificial surfaces and air as well as ischemia/reperfusion injury to the heart and lungs mediate systemic and local inflammation during cardiopulmonary bypass (CPB). Activation of complement and coagulation cascades leads to and accompanies endothelial...

  • Cardiopulmonary bypass for a coronary artery bypass graft patient with heterozygous protein C deficiency and protein S deficiency. Schneider, Susan; Sakert, Tamara; Lucke, John; McKeown, Peter; Sharma, Ajeet // Perfusion;Mar2006, Vol. 21 Issue 2, p117 

    Cardiopulmonary bypass (CPB) poses great risks for hypercoagulable patients and requires management techniques to ensure an optimal outcome free from thrombotic events. This case report reviews perfusion management techniques that may contribute to a safer CPB experience for a patient deficient...

  • Levels of Protein C and Protein S, Tissue-Plasminogen Activator, and Fibrinogen During Cardiopulmonary Bypass. Yahya6Ünlü; Tekın, Salim B.; Koçak, Hikmet // Turkish Journal of Medical Sciences;2007, Vol. 37 Issue 6, p345 

    Aim: The exposure of blood to foreign surfaces during cardiopulmonary bypass (CPB) leads to an activation of the coagulation system. The goal of this study was to evaluate the levels of protein C and protein S, tissue-plasminogen activator (t-PA) and fibrinogen before, during and after CPB....

  • New Treatment Method Possible in Cardiac Surgery.  // Research Journal of Cardiology;2011, Vol. 4 Issue 1, p60 

    The article discusses the results of a clinical trial conducted by the University of Hospital and the University of Gothenburg in Sweden which found that fibrinogen is likely more vital to the blood's clotting ability. According to Doctor Martin Karlsson, the use of a cardiopulmonary bypass...

  • Bivalirudin.  // Reactions Weekly;10/29/2011, Issue 1375, p8 

    The article describes the case of a 48-year-old man who developed coagulopathy while under bivalirudin treatment regimen for anticoagulation during cardiopulmonary bypass (CBP) surgery. The patient underwent surgery using deep hypothermic circulatory arrest (DHCA). He was successfully treated...

  • Evaluation of coagulation factors and platelet function from an off-line modified ultrafiltration technique for post-cardiopulmonary bypass circuit blood recovery. Beckmann, S; Lynn, P; Miller, S; Harris, R; Dimarco, Rf; Ross, Je // Perfusion;May2013, Vol. 28 Issue 3, p214 

    Modified ultrafiltration (MUF) is a technique that hemoconcentrates residual CPB circuit blood and the patient at the same time. Hemoconcentration and MUF are Class 1-A recommendations in the anesthesia and surgical blood conservation guidelines. This study evaluated the off-line MUF process of...

  • Thrombin and Cardiopulmonary Bypass -- A Paradigm for Evaluation of the Regulation of Hemostasis. Ferraris, Victor A.; Ferraris, Suellen P. // International Journal of Angiology (Springer Science & Business ;Winter2005, Vol. 14 Issue 4, p193 

    Extracorporeal circulation for the purpose of cardiopulmonary bypass (CPB) is used extensively for repair of cardiac defects. Complex mechanisms, many of which involve the generation of thrombin, are initiated by the institution of CPB. Thrombin is generated during CPB in spite of high doses of...

  • Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass. Guzzetta, N. A.; Szlam, F.; Kiser, A. S.; Fernandez, J. D.; Szlam, A. D.; Leong, T.; Tanaka, K. A. // BJA: The British Journal of Anaesthesia;Feb2014, Vol. 112 Issue 2, p319 

    Introduction Factor concentrates are currently available and becoming increasingly used off-label for treatment of bleeding. We compared recombinant activated factor VII (rFVIIa) with three-factor prothrombin complex concentrate (3F-PCC) for the ability to augment thrombin generation (TG) in...

  • Restoration of the coagulation cascade on CPB: a case report. Lilly, KJ; Pirundini, PA; Fox, AA; Body, SC; Shaw, C; Rizzo, RJ // Perfusion;May2014, Vol. 29 Issue 3, p272 

    Coagulopathy can sometimes be observed when CPB times are prolonged. Correction of coagulopathy post CPB can present the surgical team with a number of challenges, including right ventricular volume overload, hemodilution, anemia and excessive cell salvage with further loss of coagulation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics